(Press-News.org) BOSTON – March 13, 2013 – Joslin scientists have discovered a mechanism that regulates the production of brown fat, a type of fat which plays an important role in heat production and energy metabolism. The findings, which appear in the upcoming issue of Nature, may lead to new therapies that increase BAT formation to treat obesity.
Two types of fat tissue are present in humans and other mammals: white adipose tissue (WAT) or white fat, which stores fat; and brown adipose tissue (BAT) or brown fat, which burns fat to produce heat. Brown fat also metabolizes glucose and fatty acids which is important in diabetes and metabolic diseases. Studies suggest that brown fat provides a natural defense against obesity: people with greater quantities of brown fat have lower body weights. This has made brown fat the focus of considerable interest among scientists and pharmaceutical companies looking for ways to treat obesity.
Joslin scientists in the Tseng Laboratory of the Section on Integrative Physiology and Metabolism previously discovered that one type of bone morphogenetic protein, BMP-7, plays a key role in the control of brown fat formation and its heat-producing activity, which regulates whole body metabolism. In the present study, the scientists created a genetically mutant mouse model deficient in type 1A BMP-receptor (BMPR1A), a key receptor for BMP-7 which has been shown to be associated with obesity in human populations.
Mice have two types of BAT: constitutive BAT (cBAT), which develops before birth; and recruitable BAT (rBAT), which is found in WAT and skeletal muscle. Humans may also have two types of BAT.
The mice lacking BMPR1A were born with a deficiency of cBAT. Despite their lack of cBAT, the mutant mice were able to "maintain their body temperature perfectly," says senior author Yu-Hua Tseng, Ph.D., Assistant Professor of Medicine at Harvard Medical School, Principal Faculty of the Harvard Stem Cell Institute and an Investigator in the Section on Integrative Physiology and Metabolism.
The scientists discovered that when cBAT is deficient, cBAT cells send a signal through the sympathetic nervous system to increase production of rBAT within white fat. This study is the first to report this cross-talk between these two types of brown fat. The increased rBAT was sufficient to maintain normal body temperature and also protect against diet-induced obesity: When the control and mutant mice were fed a high-fat diet, the mutant mice did not gain more weight than the control mice.
Until this study, it was not known why a body needs two types of BAT and how they interact with each other. "These results show us that brown fat is essential for normal functioning. When one type of brown fat is deficient, the body has a sophisticated system for inducing development of the other type of brown fat to maintain body temperature and metabolism," says Dr. Tseng.
Tseng Laboratory scientists are interested in learning more about the function of human brown fat cells, including whether humans have two types of BAT, and understanding how BMP and related factors affect human brown fat production. "We would like to translate this research to develop treatments for diabetes and obesity. This new type of therapy would be especially beneficial to individuals who cannot lose weight through diet or have a limited ability to exercise," says Dr. Tseng.
INFORMATION:
The paper's lead author is Tim Schulz, a postdoctoral scientist in the Tseng Laboratory. Other contributors include Tian Lian Huang, Ruidan Xue, Lindsay McDougall, Kristy Townsend and Aaron Cypess of Joslin; Yuji Mishina of the University of Michigan; and Ping Huang and Emanuela Gussoni of Children's Hospital, Boston.
This study was funded by the National Institutes of Health, the Eli Lilly Research Foundation and the Harvard Stem Cell Institute.
About Joslin Diabetes Center
Joslin Diabetes Center, located in Boston, Massachusetts, is the world's largest diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School.
Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications. For more information, visit http://www.joslin.org.
About Joslin Research
Joslin Research comprises the most comprehensive and productive effort in diabetes research under one roof anywhere in the world. With 30‐plus faculty-level investigators and an annual research budget of $36 million, Joslin researchers focus on unraveling the biological, biochemical and genetic processes that underlie the development of type 1 and type 2 diabetes and related complications.
Joslin research is highly innovative and imaginative, employing the newest tools in genetics, genomics and proteomics to identify abnormalities that may play a role in the development of diabetes and its complications. Joslin Clinic patients, and others with diabetes, have the option of participating in clinical trials at Joslin to help translate basic research into treatment innovations.
Joslin has one of the largest diabetes training programs in the world, educating 150 M.D. and Ph.D. researchers each year, many of whom go on to head diabetes initiatives at leading institutions all over the globe. For more information, visit http://www.joslinresearch.org.
Joslin scientists discover mechanism that regulates production of energy-burning brown fat
Findings may aid the prevention and treatment of obesity
2013-03-14
ELSE PRESS RELEASES FROM THIS DATE:
Tobacco industry appears to have evaded FDA ban on 'light' cigarette descriptors
2013-03-14
Boston, MA – New research from Harvard School of Public Health (HPSH) shows that one year after the federal government passed a law banning word descriptors such as "light," "mild," and "low" on cigarette packages, smokers can still easily identify their brands because of color-coding that tobacco companies added to "light" packs after the ban. These findings suggest that the companies have, in effect, been able to evade the ban on misleading wording—thus still conveying the false and deceptive message that lights are safer than "regular" cigarettes.
In addition, the ...
Ancient, highly active galaxies discovered
2013-03-14
Pasadena, CA — Using information gathered from several telescopes, a team of astronomers, including Carnegie's Eric Murphy, searched the sky for very rarely seen dusty starburst galaxies, formed soon after the Big Bang. These galaxies are characterized by an unusually high rate of star formation. They are much more abundant in the early Universe than previously thought. Two of those identified are among the oldest ever found, indicating that these dusty starbursts likely evolve into the most massive galaxies ever observed in the local Universe. The results are published ...
ALMA finds 'monster' starburst galaxies in the early universe
2013-03-14
Astronomers using the Atacama Large Millimeter/submillimeter Array (ALMA) telescope have discovered starburst galaxies earlier in the Universe's history than they were previously thought to have existed. These newly discovered galaxies represent what today's most massive galaxies looked like in their energetic, star-forming youth. The research is the most recent example of the discoveries coming from the new international ALMA observatory, which celebrates its inauguration today.
The results, published in a set of papers to appear in the journal Nature and in the Astrophysical ...
Lower incidence of genital warts in young girls
2013-03-14
The incidence of genital warts, or condylomata, declined by 93 per cent in girls given the HPV vaccine before the age of 14, according to a Swedish national registry study. The study was carried out by researchers at Karolinska Institutet in Sweden, and published in Journal of the National Cancer Institute.
Using a selection of population-based registries, the researchers at Karolinska Institutet studied 124,000 girls and women in Sweden between 10 and 44 years old who had received the HPV vaccine against condyloma and cervical cancer at some time between 2006 and 2010. ...
Shock treatment can kill -- Clinical trial shows how 'standard' procedure results in children's deaths
2013-03-14
Results from the Fluid Expansion as Supportive Therapy (FEAST) trial in East Africa show that children who are given fluid to treat shock have an increased risk of death due to cardiovascular collapse at 48 hours. These findings in BioMed Central's open access journal BMC Medicine challenge the generally held idea that early and rapid reversal of shock by fluid resuscitation translates into longer-term survival benefits.
The FEAST trial was conducted in six African hospitals across Kenya, Tanzania and Uganda without intensive care facilities. It included 3000 children ...
Tapeworm DNA contains drug weak spots
2013-03-14
For the first time, researchers have mapped the genomes of tapeworms to reveal potential drug targets on which existing drugs could act. The genomes provide a new resource that offers faster ways to develop urgently needed and effective treatments for these debilitating diseases.
Tapeworms cause two of the World Health Organization's 17 neglected tropical diseases; echinococcosis and cysticercosis. The team sequenced the genomes of four species of tapeworm to explore the genetics and underlying biology of this unusual parasite. As an adult it can live relatively harmlessly ...
Computer models predict how patients will respond to HIV drugs
2013-03-14
Results of a study published online in the Journal of Antimicrobial Chemotherapy today (Thursday), demonstrate that computer models can predict how HIV patients whose drug therapy is failing will respond to a new treatment. Crucially for patients in poorer countries, the models do not require the results of expensive drug resistance tests to make their predictions. The study also showed that the models were able to identify alternative drug combinations that were predicted to work in cases where the treatment used in the clinic had failed, suggesting that their use could ...
Drug treatment corrects autism symptoms in mouse model
2013-03-14
Autism results from abnormal cell communication. Testing a new theory, researchers at the University of California, San Diego School of Medicine have used a newly discovered function of an old drug to restore cell communications in a mouse model of autism, reversing symptoms of the devastating disorder.
The findings are published in the March 13, 2013 issue of the journal PLOS ONE.
"Our (cell danger) theory suggests that autism happens because cells get stuck in a defensive metabolic mode and fail to talk to each other normally, which can interfere with brain development ...
ALMA exposes hidden star factories in the early universe
2013-03-14
Some of the brightest galaxies in the universe – infant galaxies that churned out tens of thousands of stars each year at the dawn of the universe – evolved much sooner and in greater numbers than previously thought, according to new measurements obtained by University of Arizona astronomers.
The results are published in a set of papers to appear in the journal Nature on March 14 and in the Astrophysical Journal. The research is the most recent example of the discoveries coming from the new international ALMA observatory, which celebrates its inauguration today. ALMA, ...
Molecule's structure reveals new therapeutic opportunities for rare diabetes
2013-03-14
ORLANDO, Fla., March 13, 2013 – Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have determined the complete three-dimensional structure of a protein called HNF-4α. HNF-4α controls gene expression in the liver and pancreas, switching genes on or off as needed. People with mature onset diabetes of the young (MODY1), a rare form of the disease, have inherited mutations in the HNF-4α protein. This first-ever look at HNF-4α's full structure, published March 13 in Nature, uncovers new information about how it functions. The study ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Joslin scientists discover mechanism that regulates production of energy-burning brown fatFindings may aid the prevention and treatment of obesity